In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
Neural and Neurite Research Models Some GHK-Cu research may include neural cells, neurite-associated measurements, or stress-response pathways
Use SPF 30+ daily, reapply every 23 hours outdoors, wear full sleeves, hats, and stay in the shade when possible
minoxidil, 1993: A small double-blind trial found that a topical GHK-Cu solution produced hair density improvements comparable to 5% minoxidil over 6 months in men with androgenetic alopecia
G.LangfordN